Jason is finally coming to grips with the signific
Post# of 30027
Quote:
The news on MANF receiving Orphan Drug designation comes 67 days after the company announced they filed the application with the FDA - one of the fastest turnarounds we recall in recent years. We believe the quick turnaround by the agency was due to a combination of factors, including a wealth of available scientific literature and preclinical data on MANF and a clear Orphan market well below the upper limit of the FDA's threshold.